Status:

COMPLETED

Attributional Style and Parkinson's Disease

Lead Sponsor:

CHU de Reims

Conditions:

Parkinson's Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Parkinson's disease (PD) is a common neurodegenerative disorder affecting 1-2% of the population over 65 years-old. In addition to the motor impairment characterized by resting tremor, bradykinesia, r...

Detailed Description

To explore attribution bias in PD population, the Ambiguous Intentions Hostility Questionnaire (AIHQ) developed by Combs (2007) will be used. The participants will be asked to read 15 vignettes, to im...

Eligibility Criteria

Inclusion

  • Inclusion criteria :
  • Diagnostic of Parkinson's disease by a neurologist
  • Native French speaker
  • Affiliated to social security
  • Unmodified PD treatment for at least 2 weeks before the inclusion
  • Over 18 years-old
  • Accepting the study after reading the information note and signing the consentment form
  • Exclusion criteria :
  • Diagnostic of bipolar disorder or schizophrenia
  • Abuse and dependence on psychoactive substances according to the DSM V criteria
  • Disabling sensory disorders
  • Mental retardation or cognitive deterioration (e.g. dementia), with the incapacity to answer to the questionnaires.
  • Patients under guardianship or curatorship

Exclusion

    Key Trial Info

    Start Date :

    January 22 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 7 2018

    Estimated Enrollment :

    32 Patients enrolled

    Trial Details

    Trial ID

    NCT03371277

    Start Date

    January 22 2018

    End Date

    July 7 2018

    Last Update

    October 26 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Chu Reims

    Reims, France, 51092